RESUMO
Incapacitating dysmenorrhea has been treated in many different ways both medical and surgical. The best result yet is by uterosacral ablation. The purpose of this study is to demonstrate the utility of uterosacral ablation as treatment for incapacitating dysmenorrhea. This is a prospective longitudinal study of a cohort in which patients were their own controls. The no probabilistic sample of work was of 15 patients in the service of Gynecology being studied for incapacitating primary dysmenorrhea, under treatment for at least three months without favorable response. Videolaparoscopy was performed using CO2 as distention gas. A 10 mm lens grand angular Storz Karl and monopolar feeding was used for the ablation. Follow up was for six to sixteen months, grading the response to treatment in absent, mild, moderated and good. Considering a good response was when pain allowed daily activity. X2 was used at a level of significance of 0.05. In relationship with pain one (7%) was asintomatic, nine (50%) were mild, three (20%) moderate, two (13%) remained with no changes. Comparing the difference pre and post treatment had, statistical significance on a P 0.0025 was in favor of the improvement. We conclude in spite of the smallness of the sample, results are encouraging because any degree of improvement is of benefit to the patient for her quality of life.
Assuntos
Dismenorreia/cirurgia , Laparoscopia/métodos , Plexo Lombossacral/cirurgia , Gravação em Vídeo , Adolescente , Adulto , Dismenorreia/fisiopatologia , Feminino , Humanos , Resultado do TratamentoRESUMO
In 138 patients with uterine dysfunctional bleeding a hormonal treatment with chlormadinone acetate, was given. The dosage varied according to four therapeutic stages: hemostatic, maintenance, consolidation and observation. Patients were placed in three groups: Group I, adolescents, Group II, reproductive life, Group III, premenopausal. In 51.9% of the patients there was endometrial hyperplasia, proliferative in 26.6% and secretory in 14.1%. Good results were obtained in all four therapeutic stages.